Homogeneous Catalysis
FULL PAPER
AD-H [126], hexane/EtOH, 99.95:0.05, flow rate 0.5 mLminÀ1): tR =
12.49, 13.18 min.
HRMS calcd for C16H17NO3S: 303.09293; found: 303.09398; HPLC
(Whelk01 [R,R], hexane/EtOH, 90:10, flow rate 1.0 mLminÀ1): tR =10.01,
11.38 min.
trans-2-Chloromethyl-3-phenyloxirane: 1H NMR (400.1 MHz, CDCl3):
d=3.28 (ddd, J=5.8, 4.8, 1.9 Hz, 1H), 3.66 (dd, J=11.8, 5.8 Hz, 1H),
3.72 (dd, J=11.8, 4.8, Hz, 1H), 3.82 (d, J=1.9 Hz, 1H), 7.26–7.38 ppm
(m, 5H); 13C NMR (100.6 MHz, CDCl3): d=44.3, 58.5, 60.9, 116.6, 125.6,
128.6, 135.9 ppm; GC-MS: m/z: 168 [M]+; HPLC (Chiralpak AD-H,
hexane/EtOH, 95:5, flow rate 1.0 mLminÀ1): tR =7.62, 9.09 min.
cis-2-Methyl-3-phenyloxirane: 1H NMR (400.1 MHz, CDCl3): d=1.07 (d,
J=5.4 Hz, 3H), 3.33 (dd, J=5.4, 4.3 Hz, 1H), 4.05 (d, J=4.3 Hz, 1H),
7.25–7.36 ppm (m, 5H); 13C NMR (100.6 MHz, CDCl3): d=12.5, 55.1,
57.5, 126.5, 127.4, 128.0, 135.5 ppm; MS (EI, 70 eV): m/z: 134 [M]+;
HPLC (Chiralcel OD-H, hexane/EtOH, 99.95:0.05, flow rate
1.0 mLminÀ1): tR =11.64 (2S,3R), 15.56 min (2R,3S).
trans-2,3-Diphenyloxirane: 1H NMR (400.1 MHz, CDCl3): d=7.24–7.31
(m, 10H), 3.87 ppm (s, 2H); 13C NMR (100.6, MHz, CDCl3): d=137.1,
128.6, 128.6, 125.5, 62.8 ppm; MS (EI, 70 eV): m/z (%): 197 (18) [M+1]+,
196 (100) [M]+, 195 (72), 178 (28), 167 (85), 90 (66), 89 (65); HPLC
(Chiralcel OD-H, hexane/EtOH, 98:2, flow rate 0.5 mLminÀ1): tR =14.10
(2S,3S), 4.79 min (2R,3R).
trans-2-Methyl-3-phenyloxirane: 1H NMR (400.1 MHz, CDCl3): d=1.44
(d, J=5.2 Hz, 3H), 3.03 (dq, J=5.2, 2.0 Hz, 1H), 3.57 (d, J=2.0 Hz, 1H),
7.23–7.4 ppm (m, 5H); 13C NMR (100.6 MHz, CDCl3): d=18.0, 59.2,
59.6, 125.7, 128.1, 128.5, 137.9 ppm; MS (EI, 70 eV): m/z (%): 134 (52)
[M]+, 133 (65), 105 (51), 91 (42), 90 (100), 89 (77), 77 (23); HPLC (Chir-
alcel OD-H (069), hexane/EtOH, 99.95:0.05, flow rate 1.0 mLminÀ1): tR =
11.90 (2S,3S), 13.48 min (2R,3R).
1
1H NMR
(400.1 MHz,
3-Phenyl-allyl ester of acetic acid: H NMR (400.1 MHz, CDCl3): d=2.07
trans-2-(p-methoxyphenyl)-3-methyloxirane:
(s, 3H), 4.83 (dd, J=6.6, 1.7 Hz, 2H), 5.80 (dt, J=11.8, 6.6 Hz, 1H), 6.65
(d, J=11.8 Hz, 1H), 7.20–7.22 (m, 2H), 7.24–7.28 (m, 1H), 7.32–
7.36 ppm (m, 2H); 13C NMR (100.6 MHz, CDCl3): d=20.94, 61.47,
125.75, 127.50, 128.36, 128.69, 132.95, 135.99, 170.88 ppm; MS (EI,
70 eV): m/z: 176 [M]+.
2-Methyl-2-phenyloxirane: 1H NMR (400.1 MHz, CDCl3): d=1.65 (s,
3H), 2.73 (d, J=5.4 Hz, 1H), 2.90 (d, J=5.4 Hz, 1H), 7.17–7.31 ppm (m,
5H); 13C NMR (100.6 MHz, CDCl3): d=56.9, 57.2, 125.4, 127.6, 128.5,
141.3 ppm; MS (EI, 70 eV): m/z (%): 134 (35) [M]+, 133 (87), 105 (100),
104 (41), 103 (58), 91 (23), 79 (37), 78 (54), 77 (49); HPLC (Chiralcel
OD-H, hexane/iso-propanol, 99.95:0.05, flow rate 1.0 mLminÀ1): tR =9.78,
12.77 min.
2-Phenyl-1-oxaspiro[2.5]octane: 1H NMR (400.1 MHz, CDCl3): d=1.22–
1.31 (m, 2H), 1.37–1.85 (m, 8H), 3.85 (s, 1H), 7.23–7.34 ppm (m, 5H);
13C NMR (100.6 MHz, CDCl3): d=?24.5, 25.3, 25.5, 28.4, 35.4, 64.5, 65.5,
126.3, 127.2, 127.9, 136.3 ppm; MS (EI, 70 eV): m/z: 188 [M]+; HPLC
(Chiralpak AD-H, hexane/EtOH, 90:10, flow rate 1.0 mLminÀ1): tR =
4.34, 4.72 min.
2,2-Dimethyl-3-phenyloxirane: 1H NMR (400.1 MHz, CDCl3): d=1.04 (s,
3H), 1.45 (s, 3H), 3.83 (s, 1H), 7.21–7.33 ppm (m, 5H); 13C NMR
(100.6 MHz, CDCl3): d=17.9, 24.7, 61.0, 64.5, 126.3, 127.3, 128,
136.6 ppm; MS (EI, 70 eV): m/z (%): 148 [M]+; HPLC (Chiralcel OD-H,
hexane/EtOH, 99.95:0.05, flow rate 0.5 mLminÀ1): tR =11.78 (3S),
18.63 min (3R).
CD2Cl2): d=1.41 (d, J=5.2 Hz, 3H), 3.01 (qd, J=5.2, 2.0 Hz, 1H), 3.50
(d, J=2.0 Hz, 1H), 3.79 (s, 3H), 6.87 (d, J=8.9 Hz, 2H), 7.17 ppm (d, J=
8.9 Hz, 2H); 13C NMR (100.6 MHz, CD2Cl2): d=18.0, 58.9, 59.5, 114.1,
127.2, 130.3, 160.0 ppm; MS (EI, 70 eV): m/z (%): 165 (7) [M+1]+, 164
(57) [M]+, 121 (47), 120 (82), 105 (31), 91 (100), 77 (55), 51 (37); HPLC
(Chiralpak AD-H, hexane/EtOH, 99.95:0.05, flow rate 1.5 mLminÀ1):
tR =16.70, 19.84 min.
1
trans-3-Phenyloxiranylmethyl acetate: H NMR (400.1 MHz, CDCl3): d=
2.04 (s, 3H), 3.18–3.20 (m, 1H), 3.73 (d, J=2.0 Hz, 1H), 4.02 (dd, J=
12.3, 6.0 Hz, 1H), 4.41 (dd, J=12.3, 3.4 Hz, 1H), 7.17–7.32 ppm (m, 5H);
13C NMR (100.6 MHz, CDCl3): d=20.7, 56.4, 59.2, 64.2, 125.6, 128.4,
128.5, 136.1, 170.7 ppm; MS (EI, 70 eV): m/z (%): 192 (2) [M]+, 150 (10),
149 (79), 133 (26), 107 (95), 105 (67), 91 (54), 90 (45), 89 (42), 79 (31), 77
(31), 43 (100); HPLC (Chiralcel OD-H, hexane/EtOH, 95:5, flow rate
1.0 mLminÀ1): tR =4.64, 5.88 min.
trans-2-[(tert-Butyldimethylsiloxy)methyl]-3-phenyloxirane:
1H NMR
(400.1 MHz, CDCl3): d=0.09 (s, 3H), 0.10 (s, 3H), 0.91 (s, 9H), 3.12–3.13
(ddd, J=4.4, 2.8, 1.9 Hz, 1H), 3.79 (d, J=1.9 Hz, 1H), 3.81 (dd, J=12.0,
4.4 Hz, 1H), 3.95 (dd, J=12.0, 2.8 Hz, 1H), 7.24–7.35 ppm (m, 5H);
13C NMR (100.6 MHz, CDCl3): d=À5.3, 18.4, 25.9, 55.9, 62.7, 64.0, 125.7,
128.1, 128.4, 137.2 ppm; MS (EI, 70 eV): m/z: 249 [MÀCH3]+; HPLC
(Whelk01 [R,R], hexane/2-propanol, 99:1, flow rate 0.5 mLminÀ1): tR =
6.30, 8.19 min.
trans-2-Methoxymethyl-3-phenyloxirane: 1H NMR (400.1 MHz, CDCl3):
d=3.19 (ddd, J=5.2, 3.1, 2.1 Hz, 1H), 3.43 (s, 3H), 3.52 (dd, J=11.4,
5.2 Hz, 1H), 3.76 (dd, J=11.4, 3.1 Hz, 1H), 3.78 (d, J=2.1 Hz, 1H),
7.25–7.35 ppm (m, 5H); 13C NMR (100.6 MHz, CDCl3): d=55.7, 59.2,
60.9, 72.1, 125.6, 128.2, 128.4, 136.8 ppm; MS (EI, 70 eV): m/z: 164 [M]+;
HPLC (Chiralcel OD-H, hexane/EtOH, 98:2, flow rate 1.0 mLminÀ1):
tR =4.53, 5.53 min.
2-Methyl-2,3-diphenyloxirane: 1H NMR (400.1 MHz, CDCl3): d=1.48 (s,
3H), 3.98 (s, 1H), 7.30–7.34 (m, 2H), 7.37–7.42 (m, 6H), 7.45–7.48 ppm
(m, 2H); 13C NMR (100.6 MHz, CDCl3): d=16.7, 63.0, 67.1, 125.1, 126.5,
127.5, 127.6, 128.2, 128.4, 135.9, 142.3 ppm; MS (EI, 70 eV): m/z: 210
[M]+; HPLC (Whelk 0.1 [R,R], hexane/EtOH, 99:1, flow rate
0.6 mLminÀ1): tR =5.33, 5.97 min.
2,2,3-Trimethyl-3-phenyloxirane: 1H NMR (400.1 MHz, CDCl3): d=0.95
(s, 3H), 1.46 (s, 3H), 1.61 (s, 3H), 7.20–7.23 (m, 1H), 7.27–7.33 ppm (m,
4H); 13C NMR (100.6 MHz, CDCl3): d=20.7, 21.3, 21.7, 63.7, 66.5, 126.0,
126.7, 128.0, 142.2 ppm; MS (EI, 70 eV): m/z: 162 [M]+; HPLC (Chiral-
pak AD-H, hexane, flow rate 1.0 mLminÀ1): tR =6.23, 6.74 min.
trans-2-Phenoxymethyl-3-phenyloxirane: 1H NMR (400.1 MHz, CDCl3):
d=3.40 (ddd, J=5.2, 3.2, 2.0 Hz, 1H), 3.91, (d, J=2.0 Hz, 1H), 4.14 (dd,
J=11.2, 5.2 Hz, 1H), 4.32 (dd, J=11.2, 3.2 Hz, 1H), 6.94–7.00 (m, 3H),
7.27–7.38 ppm (m, 7H); 13C NMR (100.6 MHz, CDCl3): d=56.4, 60.2,
67.8, 114.7, 121.3, 125.7, 128.4, 128.5, 129.5, 136.5, 158.4 ppm; MS (EI,
70 eV): m/z: 226 [M]+; HPLC (Chiralcel OD-H, hexane/EtOH, 98:2,
flow rate 1.0 mLminÀ1): tR =5.98, 6.89 min.
Computation: All calculations were carried out by using the Gaussian 98
program.[50] All structures were optimized at B3LYP density functional
level of theory with the LANL2DZ[51] basis set, and characterized as
energy minimum structures without imaginary number of frequencies at
the same level of theory (B3LYP/LANL2DZ).[52]
1
trans-2-(3-Phenyloxiranyl)-[1,3]dioxolane: H NMR (400.1 MHz, CDCl3):
d=3.13 (dd, J=3.8, 2.0 Hz, 1H), 3.89 (d, J=2.0 Hz, 1H), 3.89–3.97 (m,
2H), 4.00–4.06 (m, 2H), 5.00 (d, J=3.8, 1H), 7.25–7.35 ppm (m, 5H);
13C NMR (100.6 MHz, CDCl3): d=55.2, 61.3, 65.3, 65.5, 102.3, 125.7,
128.3, 128.4, 136.2 ppm; GC-MS: m/z: 192 [M]+; HPLC (Chiralpak AD-
H, hexane/EtOH, 95:5, flow rate 1.0 mLminÀ1): tR =25.57, 28.44 min.
4-Methyl-N-(trans-3-phenyl-oxiranylmethyl)benzenesulfonamide:
M.p.
Acknowledgements
128–1318C; Rf =0.23 (hexane/ethyl acetate=3:1); 1H NMR (400.1 MHz,
CDCl3): d=2.41 (s, 3H), 3.10 (ddd, J=4.6, 3.4, 2.0 Hz, 1H), 3.23 (ddd,
J=14.1, 6.8, 4.6 Hz, 1H), 3.38 (ddd, J=14.1, 6.0, 3.4 Hz, 1H), 3.74 (d, J=
2.0 Hz, 1H), 4.82 (unresolved dd, 1H), 7.14–7.17 (m, 2H), 7.28–7.31 (m,
5H), 7.74 ppm (d, J=8.3 Hz, 2H); 13C NMR (100.6 MHz, CDCl3): d=
21.51, 43.70, 55.55, 60.12, 125.66, 127.06, 128.51, 128.88, 129.84, 131.04,
135.69, 135.89, 136.71, 143.75 ppm; MS (EI, 70 eV): m/z: 303 [M]+;
This work has been financed by the State of Mecklenburg-Western Pom-
merania, the Bundesministerium für Bildung und Forschung (BMBF)
and the Deutsche Forschungsgemeinschaft (SPP “Sekundäre Wechselwir-
kungen”). We thank Prof. Dr. M. Michalik, Dr. W. Baumann, C. Mewes,
H. Baudisch, A. Lehmann, and S. Buchholz (all IfOK) for their excellent
technical and analytical support. Dr. A. Kçckritz (ACA) is thanked for
Chem. Eur. J. 2006, 12, 1875 – 1888
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1885